According to the World Health Organization (WHO), approximately 80 per cent of the population globally is at risk of ...

With the arrival of the monsoon season, a spike in vector-borne diseases is often observed. Health experts share tips to ...

Two imported cases of chikungunya fever were reported last week, raising the total this year to 13 cases — the most for the ...

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any ...

A landmark global modeling study reveals that more than 2.8 billion people in 104 countries are at risk of chikungunya, with ...

The Health and Mass Media Ministry has announced a Special Mosquito Control Week from June 30 to July 5, in response ...

Valneva has reported encouraging six-month safety and antibody persistence data from the multi-centre Phase II trial, VLA1553-221, of its chikungunya vaccine, Ixchiq, in 304 healthy paediatric ...

The FDA approval of Vimkunya has given the chikungunya vaccine’s owner, Bavarian Nordic, an extra financial windfall. | The ...

A countrywide Dengue and Chikungunya eradication programme will be conducted across all schools in the country on July 9, ...

Dr. Harindu Wijesinghe is a medical specialist in Rheumatology and Rehabilitation, as well as in Sports Medicine. He ...

Climate change is reshaping Europe’s disease landscape, with tropical mosquito-borne illnesses like dengue and chikungunya poised to transition from occasional outbreaks to permanent fixtures ...

UK's medicine regulator said on Monday it has temporarily restricted the use of French vaccine maker Valneva's shot to protect against chikungunya, a virus transmitted by mosquitoes, in people ...